Categories: Life Sciences

Saint John healthcare marketing platform elandas expands mobile team, hires CMO

elandas CEO Ryan Roberts

elandas, a Saint John, New Brunswick-based Life Sciences sales and marketing data company, has appointed Hayley Bohan as its chief marketing officer, and has hired four new developers with support from the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP).

“It is thrilling to be part of a company that is using technology to enhance the way people work, and give them new ways to succeed in fiercely competitive environments,” says Bohan. “The compliance challenges and data overload issues facing sales and marketing teams in the pharmaceutical and medical device worlds right now are significant, and elandas is here to help with a highly customizable set of tools that can speed time to market by getting critical information in the hands of prescribers sooner, and also deliver more actionable market insights to the field sales teams.”

The elandas platform provides a highly configurable dashboard suite for marketing professionals working in pharmaceutical and medical device sales.

Marketing in healthcare is vastly different than marketing in general, for compliance reasons, for example, that can see copy held up for weeks or months while it’s vetted, which can also have an effect on patients.

“When I was working in the pharmaceutical industry in the United States some years back, I saw firsthand how inefficiencies in getting updated and compliant educational and sales materials into the hands of pharmaceutical and medical device sales teams were causing delays in getting prescriptions written for life-saving drugs and health monitoring devices for people who desperately needed them,” said elandas CEO Ryan Roberts in a recent interview with Electronic Products and Technology. “I knew this was a solvable problem, and I made a decision to utilize my business, technological and systems expertise to build a team that would be able to overcome it.”

A few of elandas’ key customers are Johnson & Johnson Health Care Systems, Lifescan, Janssen Pharmaceuticals and Forest Pharmaceutical.

CEO Ryan Roberts hints that elandas will be unveiling a new mobile offering in the first half of 2016.

Tagged with: elandas
Terry Dawes

Recent Posts

This analyst likes Calian Group right now

Ventum analyst Rob Goff maintained a “Buy” rating and $94.00 target on Calian Group (Calian Group Stock Quote, Chart, News,… [Read More]

1 hour ago

Telus upgraded to “Buy” at TD

TD Cowen analyst Vince Valentini upgraded Telus  (Telus Stock Quote, Chart, News, Analysts, Financials TSX:T) to “Buy” from “Hold”, saying… [Read More]

3 hours ago

Should you sell your Polaris stock?

Roth Capital Markets analyst Scott Stember maintained a “Neutral” rating on Polaris (Polaris Stock Quote, Chart, News, Analysts, Financials NYSE:PII)… [Read More]

9 hours ago

Will AI kill Shopify?

National Bank Financial analyst Richard Tse said the impact of AI on tech valuations is becoming more company-specific, with names… [Read More]

14 hours ago

Meta is the best “Magnificent Seven” stock right now, this investor says

ScotiaMcLeod Newman Group advisor and portfolio manager Greg Newman told BNN Bloomberg’s Market Call on April 24 that Meta Platforms … [Read More]

1 day ago

GLP-1 trade? McKesson is your stock, this investor says

Goodreid Investment Counsel president and CEO Gordon Reid told BNN Bloomberg’s Market Call on April 23 that McKesson (McKesson Stock… [Read More]

1 day ago